eyewireplus Profile Banner
Eyewire+ Profile
Eyewire+

@eyewireplus

Followers
9K
Following
3K
Statuses
6K

Eyewire+ keeps readers updated with the latest in the #ophthalmology field, featuring breaking news from press releases, medical journals, vision publications,

Joined July 2009
Don't wanna be here? Send us removal request.
@eyewireplus
Eyewire+
2 days
Pykus Therapeutics announced that it will present initial clinical data on its investigational retinal sealant, PYK-2101, to replace gas and oil during retinal detachment repair:
0
1
3
@eyewireplus
Eyewire+
3 days
CoFi announced it has reached a new milestone of more than 10,000 ophthalmologists and optometrists active on the CoFi platform:
0
0
0
@eyewireplus
Eyewire+
3 days
The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology. Continue on here:
0
0
1
@eyewireplus
Eyewire+
3 days
Qlaris Bio announced positive topline results from two US phase 2 clinical trials investigating QLS-111 in patients with primary open angle glaucoma (POAG) and ocular hypertension (OHT):
0
0
0
@eyewireplus
Eyewire+
4 days
The FDA has approved Genentech's Susvimo ocular implant (ranibizumab) 100 mg/mL for the treatment of diabetic macular edema (DME):
0
5
5
@eyewireplus
Eyewire+
5 days
Rayner announced the closure of recruitment in the Investigational Device Exemption (IDE) study for the RayOne Galaxy IOL in the United States:
0
0
0
@eyewireplus
Eyewire+
5 days
👁️ Eyewire+ Weekly Digest is here! Stay ahead with the latest in ophthalmology & optometry. Plus, fresh podcasts and expert insights from every subspecialty. Get the full update below!
0
0
0
@eyewireplus
Eyewire+
8 days
Iantrek announced the completion of the first commercial cases utilizing its C.Rex micro-interventional system for canal outflow enhancement in glaucoma surgery:
1
1
2
@eyewireplus
Eyewire+
8 days
BVI Medical announced the launch of EyeXchange Solutions, a platform designed to enhance vision care through comprehensive educational resources and clinical support:
0
0
1
@eyewireplus
Eyewire+
9 days
The latest headlines in ophthalmology are now on Eyewire News: The Podcast! Listen to this week's episode to learn industry updates. Listen here:
0
1
0
@eyewireplus
Eyewire+
9 days
Harrow announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora:
0
0
0
@eyewireplus
Eyewire+
9 days
The American Academy of Optometry Foundation (AAOF) and Meta Reality Labs Research (RLR) have launched a new grant opportunity aimed at advancing research in the field of myopia and its connection to visual experience:
0
0
0
@eyewireplus
Eyewire+
10 days
The world's first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; The European Commission approves a biosimilar to Eylea; And we review several clinical updates in the development of ophthalmic drugs:
0
0
0
@eyewireplus
Eyewire+
11 days
Norlase announced the FDA 510(k) clearance and CE Mark for Norlase LYNX, which the company describes as the world’s first and only pattern scanning laser indirect ophthalmoscope:
0
1
0
@eyewireplus
Eyewire+
12 days
CooperVision has appointed Steven Robins as President, Americas, effective immediately. He has served for 3 decades in health care, with several high-profile corporate leadership and consulting roles in the vision care industry:
0
0
0
@eyewireplus
Eyewire+
15 days
Listen to the latest news in ophthalmology: Zeiss Receives FDA Approval for the MEL 90 Excimer Laser; Bausch + Lomb Bolsters Glaucoma and GA Pipeline; and Rayner Launches RayOne Galaxy and RayOne Galaxy Toric IOLs:
0
0
1
@eyewireplus
Eyewire+
16 days
Hoya Vision Care announced the launch of an extended power range for its MiYOSMART spectacle lenses, offering a new solution for children suffering from high myopia:
0
1
2
@eyewireplus
Eyewire+
17 days
Zeiss receives a major approval for its new excimer laser; Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and GA; and Rayner announces the full European launch of its RayOne Galaxy IOLs. Catch our newest edition of EyewireTV here:
0
0
0
@eyewireplus
Eyewire+
18 days
Pantheon Vision announced the completion of its third meeting with the FDA review team as the company continues its development of bioengineered corneal implants, designed to address the global challenge of corneal blindness:
0
0
0
@eyewireplus
Eyewire+
18 days
Rayner announced the approval of RayOne EMV Toric IOL by Health Canada:
0
0
0